Scientists at Georgetown Lombardi Comprehensive Cancer Center and the National Cancer Institute have discovered why intrinsic resistance occurs to lung cancer targeted therapy—and they have pinpointed a type of drug they say could potentially reverse it.

READ FULL ARTICLE Curated publisher From National Cancer Institute